What's Going On With Neutrogena Maker Kenvue Stock On Thursday?
Kenvue Inc. (NYSE:KVUE) shares are down during Thursday’s premarket session, with no news. Over the last six months, the company’s stock has fallen by around 15%.
In January, the company said it is moving forward with its acquisition process by Kimberly-Clark Corporation (NYSE:KMB).
Kenvue and Kimberly-Clark shareholders overwhelmingly approved the proposals necessary for Kimberly-Clark to complete its acquisition of Kenvue, with approximately 99% of shares voted in favor at Kenvue’s Special Meeting. The transaction is expected to close in the second half of 2026, pending regulatory approvals.
The approval marks a significant milestone in creating a global health and wellness leader, with Kenvue’s CEO, Kirk Perry, expressing confidence in the growth opportunities ahead for the combined company.
This merger aims to enhance innovation and expand access to their trusted brands, which include well-known names like Tylenol and Listerine.
In November 2025, a Texas judge declined to halt an upcoming shareholder payout by Texas Attorney General Ken Paxton to restrict Kenvue’s handling and marketing of Tylenol amid ongoing litigation over the product’s safety for pregnant women.
The ruling allows Kenvue to proceed with its planned dividend while the broader dispute continues.
Technical Analysis
Kenvue stock is currently trading 4.6% above its 20-day simple moving average (SMA) and 10.7% above its 100-day SMA, demonstrating some short-term strength. However, shares have decreased by 11.55% over the past 12 months and are positioned closer to their 52-week lows than highs.
The RSI is at 73.07, indicating that the stock is in overbought territory, which could suggest a potential pullback. Meanwhile, the MACD is above its signal line, indicating bullish momentum.
The combination of overbought RSI and bullish MACD suggests mixed momentum, indicating that while the stock has been strong, it may be due for a correction.
- Key Resistance: $19.00
- Key Support: $16.50
Earnings & Analyst Outlook
Kenvue is set to report earnings on Feb. 17, 2026.
- EPS Estimate: 22 cents (Down from 26 cents YoY)
- Revenue Estimate: $3.70 billion (Up from $3.66 billion YoY)
- Valuation: P/E of 24.7x (Indicates fair valuation)
Analyst Consensus & Recent Actions: The stock carries a Hold Rating with an average price target of $20.18. Recent analyst moves include:
- Jefferies: Downgraded to Hold (Lowers Target to $18.00) (Jan. 30)
- Barclays: Equal-Weight (Raises Target to $18.00) (Nov. 10, 2025)
- Canaccord Genuity: Downgraded to Hold (Lowers Target to $15.00) (Oct. 29, 2025)
Benzinga Edge Rankings
Benzinga Edge scorecard for Kenvue
- Value: Weak (Score: 30.35) — Trading at a steep premium relative to peers.
- Momentum: Weak (Score: 14.44) — Stock is underperforming the broader market.
The Verdict: Kenvue’s Benzinga Edge signal reveals a challenging landscape as both Value and Momentum scores indicate weakness. Investors should remain cautious as the stock navigates through company-specific challenges while preparing for upcoming earnings.
KVUE Price Action: Kenvue shares were down 0.32% at $18.48 during premarket trading on Thursday, according to Benzinga Pro data.
Piotr Swat via Shutterstock
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cerebras (CBRS.US) Cloud Business Soars, Masking Hardware Decline; OpenAI Supports Half of Cloud Revenue
Cerebras achieved record Q3 revenue, but hardware income dropped by nearly 30%, while cloud business accounted for two-thirds of total revenue. OpenAI contributed $72.4 million. The company raised its full-year guidance and expects Q4 to be close to breakeven.
Microsoft (MSFT.US) offers voluntary buyout packages to about 60,000 employees: Structural divergence in U.S. employment under AI transformation
In 2026, the U.S. labor market is characterized by both low layoffs and weak hiring. Companies like Microsoft and American Express are leveraging AI to optimize their workforce, while data centers are driving growth in the construction sector. However, entry-level white-collar jobs face increasing pressure, with real wages experiencing negative growth and structural transformation risks becoming more prominent.
"Inflation is really too high"! Federal Reserve "third-in-command": The Fed must continue to take action and promptly bring the price level back to 2%
John Williams, President of the New York Federal Reserve and the “number three” official at the Federal Reserve with a permanent voting right, stated that U.S. inflation remains high and policymakers must take further action to curb price pressures.
Jensen Huang steps down, and the "biggest patron" of new AI players is gone too
Anthropic's tens-of-billions IPO investment, Figure AI's additional $1 billion, and Nscale's over $5 billion credit guarantee are all in negotiations but their outcomes remain uncertain. Meanwhile, its $500 billion AI financing platform has stalled, and some clients are considering switching to AMD or Google. Successor Kress has a conservative style and has repeatedly vetoed deals aggressively promoted by Jensen Huang, signaling the possible end of Nvidia's era of bold investments.
Crypto prices
More
